A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation
Phase 1
Recruiting
- Conditions
- MicroBlepharoexfoliation, NuLids, iTEAR100, iLIDS100, Blepharitis, Dry Eye Syndrome
- Interventions
- Device: iLIDS100
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Olympic Ophthalmics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06235450
- Locations
- ๐บ๐ธ
Olympic Ophthalmics, Issaquah, Washington, United States
Usability, Immediate, and 30 Day Effect of External Neuromodulation With iTEAR100 Generation 2 in Dry Eye Patients
Phase 4
- Conditions
- Dry Eye
- Interventions
- Device: iTEAR100 treatment
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Olympic Ophthalmics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT05304637
- Locations
- ๐บ๐ธ
Olympic Ophthalmics, Issaquah, Washington, United States
๐บ๐ธPeriman Eye Institute, Seattle, Washington, United States
A Usability Study of External Neuromodulation With iTEAR100 Generation 2
Phase 4
- Conditions
- Dry Eye Syndromes
- Interventions
- Device: iTEAR100
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- Olympic Ophthalmics, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05304650
- Locations
- ๐บ๐ธ
Olympic Ophthalmics, Issaquah, Washington, United States
Study of External Neuromodulation to Improve Signs and Symptoms of Dry Eye in Visual Display Terminal Users
Not Applicable
- Conditions
- Visual Display Users With Previously Undiagnosed Dry Eye
- Interventions
- Device: iTEAR100
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2021-02-21
- Lead Sponsor
- Olympic Ophthalmics, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT04763018
- Locations
- ๐บ๐ธ
Fishman Vision, Palo Alto, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath